Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mingqing Zhu

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Thrombosis and Haemostasis|October 30, 2020
Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis PathwayWenjing Miao, Baoquan Song, Bingyu Shi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 28, 2018
Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple MyelomaJinge Xu, Bin Liu, Shoubao Ma, et al.
Frontiers in Oncology|August 23, 2021
The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell TransplantationChang Hou, Lili Zhou, Menglu Yang, et al.
Annals of Hematology|October 7, 2024
Distinct clinical profiles and patient outcomes in aCML and CNLYingxin Sun, Qinrong Wang, Zhiyu Zhang, et al.
Haematologica|May 15, 2012
Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classificationLingzhi Yan, Nana Ping, Mingqing Zhu, et al.
Annals of Hematology|February 3, 2023
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemiaYingxin Sun, Qinrong Wang, Xingxia Zhang, et al.
Plos One|October 14, 2025
HLF gene is a poor prognostic factor in acute myeloid leukemia patients with FLT3-ITD/NPM1 mutations undergoing hematopoietic transplantationXiaoyu Xu, Xinxin Ge, Airui Jiang, et al.
Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.
American Journal of Cancer Research|October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
American Journal of Cancer Research|July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Thrombosis and Haemostasis|October 30, 2020
Immune Thrombocytopenia Plasma-Derived Exosomes Impaired Megakaryocyte and Platelet Production through an Apoptosis PathwayWenjing Miao, Baoquan Song, Bingyu Shi, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|February 28, 2018
Characterizing the Tumor Suppressor Role of CEACAM1 in Multiple MyelomaJinge Xu, Bin Liu, Shoubao Ma, et al.
Frontiers in Oncology|August 23, 2021
The Prognostic Value of Early Detection of Minimal Residual Disease as Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients After Myeloablative Allogeneic Hematopoietic Stem-Cell TransplantationChang Hou, Lili Zhou, Menglu Yang, et al.
Annals of Hematology|October 7, 2024
Distinct clinical profiles and patient outcomes in aCML and CNLYingxin Sun, Qinrong Wang, Zhiyu Zhang, et al.
Haematologica|May 15, 2012
Clinical, immunophenotypic, cytogenetic, and molecular genetic features in 117 adult patients with mixed-phenotype acute leukemia defined by WHO-2008 classificationLingzhi Yan, Nana Ping, Mingqing Zhu, et al.
Annals of Hematology|February 3, 2023
Molecular genetics and management of world health organization defined atypical chronic myeloid leukemiaYingxin Sun, Qinrong Wang, Xingxia Zhang, et al.
Plos One|October 14, 2025
HLF gene is a poor prognostic factor in acute myeloid leukemia patients with FLT3-ITD/NPM1 mutations undergoing hematopoietic transplantationXiaoyu Xu, Xinxin Ge, Airui Jiang, et al.
Oncotarget|December 20, 2017
High Tim-3 expression on AML blasts could enhance chemotherapy sensitivityLiangjing Xu, Jinge Xu, Shoubao Ma, et al.
American Journal of Cancer Research|October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
American Journal of Cancer Research|July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Pageof 4